Aspirin (75mg), Atorvastatin (40mg), Clopidogrel (75mg)
May 23, 2023
Aspirin (75mg), Atorvastatin (40mg), Clopidogrel (75mg)
ATOVASTRIN GOLD is used for individuals with certain medical conditions, particularly those at high risk of cardiovascular events.
Aspirin is an antiplatelet medication that helps prevent blood clots by inhibiting platelet aggregation.
Atorvastatin is used to lower cholesterol levels and reduce the risk of cardiovascular events.
Clopidogrel is another antiplatelet medication that is often prescribed to individuals who have had a recent heart attack, stroke, or have certain heart or blood vessel conditions.
ATOVASTRIN GOLD work synergistically to reduce the risk of blood clots, heart attacks, strokes, and other cardiovascular events. ATOVASTRIN GOLD is used in individuals who have had a recent heart attack or stroke, have undergone procedures like coronary artery stenting, or have certain heart or blood vessel conditions.
STERIS PHARMA deals in Generic medicines that are subject to the same rigorous standards to ensure their safety, quality, and efficacy.
For further information
please contact: info@sterispharma.com
Order now -
https://www.sterisonline.com/product/atovastrin-gold-40-133257
Recent Post
What Are Metformin HCl PR 850 mg & Glimepiride 3 mg Tablets?
What Is Keratin Biotin Conditioner? Everything You Need to Know
What Are Tablets of Thiamine Nitrate, Pyridoxine Hydrochloride, Folic Acid and Minerals? A Complete Guide
What Is Montelukast + Levocetirizine Syrup? A Complete Guide
How Dapagliflozin, Teneligliptin & Metformin 1000 ER Work Together for Your Heart and Sugar
The Science of BUDESHINE: How Budesonide Aqueous Spray Works for You
Best Anti-Dandruff Shampoo with Luliconazole, Salicylic Acid & Zinc Pyrithione in 2026
Managing Diabetic Neuropathy: Why Pregabalin, Methylcobalamin & Duloxetine is the Best Trio
Powerful Triple Action Cough Syrup: Terbutaline + Ambroxol + Guaiphenesin for Better Breathing
Dapagliflozin 10mg Glimepiride 2mg Metformin 500mg ER Tablets: Best Triple Therapy for Type 2 Diabetes in 2026